| scholarly article | Q13442814 |
| P2093 | author name string | Dongmei Cheng | |
| Edwin K Jackson | |||
| Delbert G Gillespie | |||
| Travis C Jackson | |||
| Jonathan D Verrier | |||
| P2860 | cites work | Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia | Q79700731 |
| Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins | Q94705295 | ||
| Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology | Q24598754 | ||
| Uric acid, hyperuricemia and vascular diseases | Q26850727 | ||
| The equilibrative nucleoside transporter family, SLC29 | Q28184224 | ||
| The concentrative nucleoside transporter family, SLC28 | Q28186657 | ||
| Ecto‐enzyme and signaling functions of lymphocyte CD 7 3 | Q28268472 | ||
| Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors | Q28362731 | ||
| Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury | Q28363475 | ||
| Molecular Cloning and Functional Characterization of Nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) Equilibrative Nucleoside Transporter Proteins (rENT1 and rENT2) from Rat Tissues | Q28577258 | ||
| 5′-Nucleotidase: molecular structure and functional aspects | Q28620587 | ||
| Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine | Q30392711 | ||
| Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. | Q31029356 | ||
| Guanine deaminase functions as dihydropterin deaminase in the biosynthesis of aurodrosopterin, a minor red eye pigment of Drosophila | Q33476746 | ||
| Adenosine: an old drug newly discovered | Q33555006 | ||
| Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. | Q33767200 | ||
| Expression and Distribution of Ectonucleotidases in Mouse Urinary Bladder | Q33886615 | ||
| Identification and characterization of a novel monoamine transporter in the human brain | Q34353039 | ||
| Role of the extracellular cAMP-adenosine pathway in renal physiology | Q34366508 | ||
| Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial Cells From Genetically Hypertensive Rats | Q34445157 | ||
| Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. | Q34539873 | ||
| Roles of adenosine in skeletal muscle during systemic hypoxia | Q34775471 | ||
| Adenosine in fibrosis. | Q35085245 | ||
| Nucleoside transporters in absorptive epithelia. | Q35126384 | ||
| Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia | Q35193886 | ||
| Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. | Q35196341 | ||
| Extracellular cAMP-adenosine pathways in the mouse kidney | Q35216799 | ||
| Mammalian nucleoside transporters | Q35668173 | ||
| Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice | Q35698980 | ||
| S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action | Q35785747 | ||
| Cyclic GMP transporters | Q35863618 | ||
| Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors | Q42487930 | ||
| Dueling nucleosides: cross-regulation of extracellular adenosine by guanosine. Focus on “Extracellular guanosine regulates extracellular adenosine levels” | Q43224380 | ||
| Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes | Q43681482 | ||
| Mechanisms of apoptosis induced by purine nucleosides in astrocytes. | Q43968136 | ||
| Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock | Q44184087 | ||
| Adenosine Kinase Inhibitors. 3. Synthesis, SAR, and Antiinflammatory Activity of a Series of l-Lyxofuranosyl Nucleosides | Q44618902 | ||
| Metabolic changes induced by ischemia and cardioplegia: a study employing cardiac microdialysis in pigs | Q44703018 | ||
| Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA. | Q44974797 | ||
| Extracellular inosine modulates ERK 1/2 and p38 phosphorylation in cultured Sertoli cells: possible participation in TNF-alpha modulation of ERK 1/2. | Q46567230 | ||
| Contribution of S-adenosylhomocysteine to cardiac adenosine formation | Q46614488 | ||
| Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. | Q50337177 | ||
| Adenosine receptor expression and function in bladder uroepithelium | Q53630059 | ||
| Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury | Q57708452 | ||
| Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors | Q60050354 | ||
| Isolation and characterization of human liver guanine deaminase | Q70047925 | ||
| Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice | Q70304628 | ||
| Irreversible inhibition of S-adenosylhomocysteine hydrolase by nucleoside analogs | Q70784898 | ||
| Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase | Q70864145 | ||
| Inhibition of S-adenosylhomocysteine hydrolase by purine nucleoside analogues | Q71175140 | ||
| Influence of lodoacetate on glycolytic intermediates and on respiration in ehrlich-lettre ascites carcinoma cells | Q72134812 | ||
| Clinical pharmacology of deoxycoformycin | Q72893755 | ||
| Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors | Q73841698 | ||
| Isolation and culture of rat microvascular endothelial cells | Q74665675 | ||
| Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats | Q77387884 | ||
| Role of adenosine in regulation of carbohydrate metabolism in contracting muscle | Q77440767 | ||
| Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth | Q77725754 | ||
| Introduction to adenosine receptors as therapeutic targets | Q36153376 | ||
| Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity? | Q36273300 | ||
| Hormonal and cytokine effects of uric acid | Q36337791 | ||
| Adenosine signaling in asthma and chronic obstructive pulmonary disease | Q36343332 | ||
| Animal model for immune dysfunction associated with adenosine deaminase deficiency | Q36403326 | ||
| HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia | Q36403983 | ||
| ATP depletion as a consequence of adenosine deaminase inhibition in man. | Q36412113 | ||
| Nucleotide metabolism and cell-cell interactions | Q36518700 | ||
| Adenosine and kidney function. | Q36525555 | ||
| Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling | Q36920475 | ||
| Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. | Q37160774 | ||
| Adenosine receptor agonists for promotion of dermal wound healing | Q37165218 | ||
| Neurotrophic effects of extracellular guanosine | Q37207104 | ||
| Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. | Q37207118 | ||
| The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury | Q37373697 | ||
| Extracellular 2',3'-cAMP is a source of adenosine | Q37446049 | ||
| Adenosine: an endogenous modulator of innate immune system with therapeutic potential | Q37493077 | ||
| Adenosine receptors in wound healing, fibrosis and angiogenesis. | Q37565195 | ||
| Adenosine receptors and the central nervous system. | Q37565205 | ||
| Adenosine receptors as drug targets | Q37691817 | ||
| Adenosine receptors: what we know and what we are learning | Q37724988 | ||
| Adenosine and the Regulation of Metabolism and Body Temperature | Q37876536 | ||
| Regulation of Leukocyte Function by Adenosine Receptors | Q37876538 | ||
| Molecular mechanisms of purine and pyrimidine nucleotide release. | Q37876540 | ||
| Adenosine receptor targeting in health and disease | Q37948081 | ||
| Presynaptic purine receptors | Q37973121 | ||
| Purine nucleosides: endogenous neuroprotectants in hypoxic brain. | Q37984097 | ||
| S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents | Q39661538 | ||
| ADA and PNP deficiencies: how it all began | Q39850207 | ||
| Overview of possible relation of defects in purine metabolism to immune deficiency | Q39850209 | ||
| Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line | Q39990412 | ||
| Inhibition of PHA and NalO4 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF) | Q40237480 | ||
| Regulation of adenosine receptor engagement by ecto-adenosine deaminase | Q40614831 | ||
| Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA) | Q40682506 | ||
| Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium. | Q40693818 | ||
| Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury | Q40889562 | ||
| Autonomic Neural Control of Cardiac Function: Modulation by Adenosine and Adenosine 5′-Triphosphate | Q41531504 | ||
| Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells. | Q41551094 | ||
| Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes | Q41745077 | ||
| Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues | Q41757477 | ||
| Extracellular purine metabolism in blood vessels (Part II): Activity of ecto-enzymes in blood vessels of patients with abdominal aortic aneurysm | Q42163599 | ||
| Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions | Q42257930 | ||
| Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase | Q42274240 | ||
| P433 | issue | 5 | |
| P304 | page(s) | C406-21 | |
| P577 | publication date | 2012-12-12 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Extracellular guanosine regulates extracellular adenosine levels | |
| P478 | volume | 304 |
| Q64982037 | 8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1. |
| Q88977347 | Adenosine causes read-through into the late region of the HPV16 genome in a guanosine-dependent manner |
| Q89860928 | Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells |
| Q49065611 | Discovery and Roles of 2',3'-cAMP in Biological Systems |
| Q43224380 | Dueling nucleosides: cross-regulation of extracellular adenosine by guanosine. Focus on “Extracellular guanosine regulates extracellular adenosine levels” |
| Q49029414 | Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems. |
| Q37256409 | Guanosine and its role in neuropathologies |
| Q38830721 | Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway |
| Q42363254 | Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation. |
| Q43640727 | Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells. |
| Q33902942 | Guanosine regulates adenosine levels in the kidney |
| Q92827160 | Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7) |
| Q38358493 | Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats. |
| Q89121958 | Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats |
| Q37726989 | Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics |
| Q41924569 | Regulation of cell proliferation by the guanosine-adenosine mechanism: role of adenosine receptors |
| Q41626648 | Secretome of Intestinal Bacilli: A Natural Guard against Pathologies |
| Q34125107 | The guanosine-adenosine interaction exists in vivo |
Search more.